MSA
CLB icon

Mason Street Advisors’s Core Laboratories CLB Stock Holding History

Mason Street Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,592
Closed -$440K – 248
2020
Q4 		$440K Sell
16,592
-97
-0.6% -$1.98K 0.01% 1214
2020
Q3 		$255K Sell
16,689
-1
-0% -$21 0.01% 1282
2020
Q2 		$339K Sell
16,690
-6,912
-29% -$124K 0.01% 1196
2020
Q1 		$244K Hold
23,602
– – 0.01% 1218
2019
Q4 		$889K Buy
23,602
+337
+1% +$15.1K 0.02% 929
2019
Q3 		$1.08M Sell
23,265
-376
-2% -$17.5K 0.02% 817
2019
Q2 		$1.24M Buy
23,641
+75
+0.3% +$4.4K 0.03% 780
2019
Q1 		$1.62M Buy
23,566
+407
+2% +$27.3K 0.03% 695
2018
Q4 		$1.38M Buy
23,159
+451
+2% +$38.9K 0.03% 675
2018
Q3 		$2.63M Buy
22,708
+87
+0.4% +$9.82K 0.05% 413
2018
Q2 		$2.85M Buy
22,621
+466
+2% +$56.7K 0.06% 357
2018
Q1 		$2.4M Buy
22,155
+423
+2% +$46.8K 0.05% 434
2017
Q4 		$2.38M Sell
21,732
-161
-0.7% -$16.1K 0.05% 434
2017
Q3 		$2.16M Buy
+21,893
New +$2.12M 0.05% 464

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mason Street Advisors's CLB Position: Q1 2021 in Review

Mason Street Advisors sold out of Core Laboratories (CLB) in Q1 2021, closing a stake of 16,592 shares — an estimated $440K sold.

Mason Street Advisors first reported a position in CLB in Q3 2017 and held it in 14 quarters. The position peaked at $2.85M in Q2 2018. 183 funds tracked by Wall St. Rank hold CLB as of Q1 2021.

  • Mason Street Advisors reported no remaining Core Laboratories position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 16,592 Core Laboratories shares in Q1 2021, an estimated $440K.
  • Mason Street Advisors first reported a position in Core Laboratories in Q3 2017 and held it in 14 quarters.
  • Mason Street Advisors's Core Laboratories position peaked at $2.85M in Q2 2018.
  • 183 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.